Results 131 to 140 of about 11,884 (322)

Neostigmine versus Sugammadex and the Relationship to Reintubation Rates in the PACU [PDF]

, 2020
Background Findings Discussion Reintubation in the post-anesthesia care unit (PACU) is a complication that may be related to residual neuromuscular blockade. Neostigmine and sugammadex have different pharmacokinetics that effect speed and completeness of
Daratha, Kenn B, Pettey, Scot, Urrutia, Delanie   +2 more
core   +1 more source

Caracterização da Utilização de Sugamadex no Centro Hospitalar de Lisboa Central - Hospital de S. José [PDF]

, 2015
Introdução O sugamadex é uma gama ciclodextrina modificada que forma um complexo com os bloqueadores neuromusculares rocurónio e vecurónio, revertendo o bloqueio neuromuscular (BNM) induzido por estes fármacos1,2,3,4.
Antas, T, Costa, A, Figueira, MF, Martins, C, Portugal, S   +4 more
core  

ROCURONIUM-INDUCED ANAPHYLAXIS: ANY EVIDENCE FOR SUGAMMADEX? [PDF]

, 2023
INTRODUCTION: Anaphylaxis during general anesthesia is estimated to occur around 1 in 3,500 cases. 90% of these cases occur at induction of anesthesia. Neuromuscular blocking drugs are thought to be the most responsible trigger, with Rocuronium being the
Elmer, Warren, Fayed, Mohamed, Gray-Buchta, Asa, Jirjees, Fadi, Makadsi, Yousif, Penning, Donald   +5 more
core   +1 more source

Evaluation of the effects of intra-arterial sugammadex and dexmedetomidine: an experimental study

Revista Brasileira de Anestesiologia
Background: Intra-arterial injection of medications may cause acute and severe ischemia and result in morbidity and mortality. There is no information in the literature evaluating the arterial endothelial effects of sugammadex and dexmedetomidine.
Volkan Hancı, Şule Özbilgin, Seda Özbal, Gonca Kamacı, Hasan Ateş, Nilay Boztaş, Bekir Uğur Ergür, Ahmet Arıkanoğlu, Osman Yılmaz, Bülent Serhan Yurtlu   +9 more
doaj   +1 more source

Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block [PDF]

, 2005
Marissa Shields, M. Giovannelli, R. K. Mirakhur, Iain Moppett, Jonathan Adams, Yvonne Hermens   +5 more
openalex   +1 more source

Sugammadex in pediatric patients

Anesthesia and Pain Medicine, 2022
Jae Moon Choi, Hong Seuk Yang
openaire   +3 more sources

Sugammadex to reverse neuromuscular blockade in a child with a past history of cardiac transplantation

Annals of Cardiac Anaesthesia, 2017
Sugammadex is a novel agent for the reversal of neuromuscular blockade. The speed and efficacy of reversal with sugammadex are significantly faster than acetylcholinesterase inhibitors, such as neostigmine.
Karen Miller, Brian Hall, Joseph D Tobias   +2 more
doaj   +1 more source

Anaphylaxis to Sugammadex [PDF]

Anaesthesia and Intensive Care, 2014
L. Savic, Sinisa Savic, Philip M. Hopkins   +2 more
openaire   +3 more sources

Emerging considerations in the reversal of neuromuscular blockade and residual block [PDF]

, 2008
Incomplete recovery following reversal of neuromuscular blockade can present as a clinical problem in surgical patients. Emerging pharmacologic solutions may prevent such adverse outcomes in the future.
CHRISTOPHER J. JANKOWSKI, JURAJ SPRUNG, WAYNE T. NICHOLSON   +2 more
core   +2 more sources

Sugammadex and laryngospasm [PDF]

Anaesthesia, 2017
S. Greenaway, S. Shah, M. Dancey
openaire   +3 more sources